Condition

Edema

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 25 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials25
Recruiting3
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

25 shown
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)NCT04606030 · 2020-10-26
RECRUITING
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)NCT04278404 · 2020-03-05
RECRUITING
Screening For BCRL In Targeted Therapy For Breast CancerNCT05142800 · 2018-12-13
RECRUITING
Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart FailureNCT06995144 · 2025-05-01
WITHDRAWN
Effect of a Focused Point-of-care Ultrasonography Screening Protocol in Hospitalized PatientsNCT07656428 · 2025-04-05
ACTIVE_NOT_RECRUITING
Naturally Controlled Decongestion Using Renal Independent System in ADHF Patients, a European RegistryNCT06401109 · 2025-02-01
UNKNOWN
Efficacy and Safety of Combination Diuretic Therapy in Patients With Acute Decompensated Heart Failure and Volume OverloadNCT06414759 · 2024-07-01
UNKNOWN
Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)NCT06011798 · 2023-08-23
COMPLETED
AquaPass Device in Treatment of CHF PatientsNCT05843201 · 2022-02-20
COMPLETED
PVP-Guided Decongestive Therapy in HFNCT05217342 · 2022-01-01
UNKNOWN
GOREISAN for Heart Failure (GOREISAN-HF) TrialNCT04691700 · 2021-01-19
ACTIVE_NOT_RECRUITING
A Dual-center Study Evaluating Clinical Acceptance of a NPWT Wound Care SystemNCT04593693 · 2020-12-10
COMPLETED
Lymphatic Function in Patients With Secondary Tricuspid Valve RegurgitationNCT04595448 · 2020-09-15
COMPLETED
Effect of Vitrectomy on the Evolution of Refractory Diabetic Macular EdemaNCT03603990 · 2018-09-01
WITHDRAWN
The Mount Sinai Diabetic Foot Ulcer Prospective TrialNCT03404895 · 2018-04-13
WITHDRAWN
Kinesio Tex Tape in Reducing Edema and Seroma After Complex Reconstructive Breast SurgeryNCT03477565 · 2018-04-03
UNKNOWN
Effect of Body Weight Loading on Urinary Electrolyte ExcretionNCT03213717 · 2017-06-13
COMPLETED
Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast CancerNCT02876107 · 2016-10-06
ACTIVE_NOT_RECRUITING
Prospective Evaluation of a Surgical Solution for Breast Cancer-Associated LymphedemaNCT02734979 · 2016-07-20
COMPLETED
Breast Edema Compression VestNCT02627976 · 2016-02-01
COMPLETED
Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior ChemotherapyNCT02411656 · 2015-06-11
ACTIVE_NOT_RECRUITING
Mild Compression Sock for Control of Lower Extremity Edema in Individuals With DiabetesNCT01529385 · 2012-02-01
COMPLETED
Effect of Normatec Pump for Relief of Leg EdemaNCT01112150 · 2010-04-01
UNKNOWN
A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure)NCT00234104 · 2004-08-01
COMPLETED
Trial Assessing the Effect of Preoperative Furosemide on Intraoperative Blood PressureNCT00115726 · 2000-09-01
COMPLETED

Common interventions

Trial status mix

COMPLETED10
UNKNOWN5
ACTIVE_NOT_RECRUITING4
RECRUITING3
WITHDRAWN3

Phase mix

NA12
PHASE45
PHASE24
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.